Spermatogenesis is a continuous and highly coordinated process of spermatozoa production. In mice, this process is believed to initiate shortly after birth with the emergence of nascent spermatogonia in the testes. However, because the nascent spermatogonia originated from the gonocytes are morphologically indistinguishable from their predecessors and there is no clear definition for the gonocytes-to-spermatogonia transition (GST), it remains unclear when and how spermatogenesis is initiated in the mouse testes. To address these questions, we characterized the emergence of nascent spermatogonia in ICR mice. We found that GST is initiated in a subset of gonocytes as early as E18.5. These nascent spermatogonia express markers typical of undifferentiated spermatogonia residing in testes of adult mice. In addition to markers expression, we identified FOXO1 nuclear-to-cytoplasmic translocation as a novel feature of GST distinguishing nascent spermatogonia from the gonocytes. Using those criteria, we demonstrated that GST requires FGF signaling. When FGF signaling was inhibited pharmacologically, gonocytes retained nuclear FOXO1 expression, did not express spermatogonial markers and failed to proliferate. We found that FGF signaling acts upstream of GDNF and RA signalings for the activation of the MEK/ERK and PI3K/ Akt pathways in germ cells during GST. Taken together, we defined the precise timing of GST and revealed FGF signaling as a master regulator of GST in the perinatal mouse testes.
Introduction
Spermatogenesis is a complex and highly coordinated process of sperm production that occurs throughout life in male animals. In the adult mouse testes, both undifferentiated spermatogonia and differentiating spermatogonia reside at the peripheries of seminiferous tubules contacting the basal membrane. The undifferentiated spermatogonia contain a small population of adult tissue-specific stem cells -the spermatogonial stem cells (SSCs). The SSCs maintain the continuity of spermatogenesis by balancing self-renewal and differentiation to replenish themselves and to generate daughter cells that are committed to spermatogenic differentiation respectively (de Rooij and Russell, 2000) . In mice, it takes around 35 days for the differentiation of spermatogonia to spermatozoa (Oakberg, 1956) . In order to secure male fertility, spermatogenesis has to be timely initiated such that spermatozoa are available for fertilization when the animals reach sexual maturity.
In the mouse embryos, the germ cell lineage begins with the specification of primordial germ cells (PGCs) at embryonic day (E) 6.25 in the extraembryonic mesoderm originated from the proximal epiblast (Saitou et al., 2002) . The PGCs migrate and reach the developing gonad by E11 after which they are enclosed in the seminiferous cords formed by the Sertoli and myoid cells in the testes (McLaren, 2003) . Once these embryonic germ cells become residents in the gonads, they are referred to as gonocytes (Clermont and Perey, 1957; reviewed in Culty, 2009 ). In the testes, gonocytes experience exponential proliferation before they progressively enter mitotic arrest from E13.5 (Nagano et al., 2000; Western et al., 2008) . A day prior to birth at E18.5, gonocytes begin to relocate from the central region to the inner periphery of seminiferous cords and attach to the basal membrane (i.e. gonocyte relocation) (Nagano et al., 2000) . Then, at postnatal day (P) 1.5 (a day after birth), gonocytes reenter the cell cycle (i.e. gonocyte reproliferation) (Nagano et al., 2000) . During gonocytes-to-spermatogonia transition (hereafter referred to as GST), gonocytes may choose between two alternative cell fates where they either give rise to undifferentiated spermatogonia or differentiating spermatogonia (de Rooij, 1998; Yoshida et al., 2006) . It is generally believed that gonocytes give rise to spermatogonia after birth at the neonatal stage (de Rooij, 1998 ). The precise timing of GST however remains unclear because there is no definitive distinction between gonocytes and the nascent spermatogonia. Mechanisms of Development 144 (2017) [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] The forkhead box O transcription factors (FOXOs) confer lifespan extension in the invertebrates (Kenyon, 2010) and positively regulate selfrenewal of hematopoietic and neural stem cells in mice (Tothova and Gilliland, 2007; Paik et al., 2009) . In reproduction, FOXO1 is required for the fertility of male mice by regulating SSC self-renewal and differentiation (Goertz et al., 2011) . In the neonatal mouse testes, FOXO1 is expressed in the cytoplasms of both the gonocytes and nascent spermatogonia (Goertz et al., 2011) . At P3 stage, FOXO1 translocates to the nuclei of future SSCs (Goertz et al., 2011) . This subcellular localization of FOXO is regulated through its phosphorylation by several kinases including a serine/threonine kinase Akt (also called protein kinase B), extracellular signal-regulated protein kinase (ERK) and p38 mitogenactivated protein kinase (p38 MAPK) (Brunet et al., 1999; Asada et al., 2007; Goertz et al., 2011) . Phosphorylated FOXO binds to 14-3-3 proteins which release it from the DNA and prevent its nuclear re-entry upon translocation to the cytoplasm (Brunet et al., 1999; Burgering and Kops, 2002) . The unique expression pattern of FOXO1 may offer an opportunity to distinguish nascent spermatogonia from the gonocytes, however FOXO1 subcellular localization in pre-natal gonocytes is unknown.
It is known that extrinsic signals regulate the cell fate decisions of spermatogonia in the postnatal testes. The glial cell line-derived neurotrophic factor (GDNF) produced by the Sertoli cells and peritubular myoid cells is required for the maintenance of SSCs (Meng et al., 2000; Chen et al., 2016) . Perturbation of GDNF signaling either through targeted disruption of Gdnf or its receptors Gfra1 (GDNF family receptor alpha-1) or Ret (Rearranged during transfection) resulted in the failure of SSCs to self-renew (Naughton et al., 2006; Sada et al., 2012) . GDNF signaling maintains SSCs through the activation of the MEK (mitogenactivated protein kinase kinase)/ERK and PI3K (Phosphatidylinositol 3-kinase)/Akt signaling pathways in these cells (Lee et al., 2007; Braydich-Stolle et al., 2007; Oatley et al., 2007; He et al., 2008; Hasegawa et al., 2013) . On the other hand, retinoic acid (RA) synthesized by the Sertoli cells is required for the differentiation of spermatogonia (Vernet et al., 2006a; Raverdeau et al., 2012) . RA stimulates the expression of Stra8 (stimulated by retinoic acid gene 8) and cKit (cellular homolog of feline sarcoma viral oncogene v-kit) in spermatogonia to induce differentiation (Pellegrini et al., 2008; Zhou et al., 2008a,b; Snyder et al., 2010; Busada et al., 2014) . The induction of KIT protein expression in spermatogonia utilizes the RA/PI3K/Akt signaling axis (Busada et al., 2015) .
Another important extrinsic signaling in the male germline development is FGF signaling. FGF9 acts downstream of the male sex-determining gene, Sry and majority of male Fgf9-null mutants exhibit male-tofemale sex reversal phenotype (Colvin et al., 2001; Schmahl et al., 2004) . It was also reported that FGF signaling is required for the longterm propagation of germline stem cells (GSCs) in culture and for the maintenance of SSCs in vivo (Kanatsu-Shinohara et al., 2003; Kubota et al., 2004; Ishii et al., 2012; Hasegawa and Saga, 2014) . Thus it appears that both GDNF and FGF signalings cooperatively regulate the self-renewal of GSCs. However, GSC expansion in vitro may not necessarily require both factors because either GDNF-independent or FGF2-independent GSC propagation is achievable depending on the strains of mice from which the GSCs were derived (Kubota et al., 2004; Takashima et al., 2015) . Although much progress has been made to elucidate the regulation of spermatogonial cell fates (i.e. to differentiate or to remain undifferentiated), the regulation of cell-fate decisions in gonocytes is underexplored. Therefore the objectives of this study are to address (1) when GST is initiated and (2) how GST is regulated in the mouse testes.
Results

Spermatogonial genes expression initiates in E18.5 gonocytes
To characterize the progression of GST, we generated developmental expression profiles of known genes that are expressed in adult spermatogonia. These include undifferentiated spermatogonial marker genes (Gfra1, Ret, Plzf and Nanos2) and differentiating spermatogonial marker genes (Stra8, Ngn3 and cKit) (Meng et al., 2000; Sada et al., 2009; Costoya et al., 2004; Buaas et al., 2004; Tsuda et al., 2003; Oulad-Abdelghani et al., 1996; Anderson et al., 2008; Nakagawa et al., 2010; Ohta et al., 2000) . We considered that the expression of Stra8 and Ngn3 signifies the progression of undifferentiated spermatogonia towards differentiation (Zhou et al., 2008a; Gely-Pernot et al., 2012; Nakagawa et al., 2010) , thus we treated them as differentiating spermatogonial marker genes together with cKit. The expression profiling of these genes in E13.5-P5.5 testes using quantitative RT-PCR (qRT-PCR) revealed that the expression of all undifferentiated spermatogonial marker genes except Nanos2 began from P0.5 (Fig. 1A) . Nanos2 showed strong expression at E13.5 and E14.5 but decreased at late embryogenesis consistent with previous report (Tsuda et al., 2003) . Nevertheless its expression increased postnatally as other undifferentiated spermatogonial markers (Fig. 1A) . Among the differentiating spermatogonial markers examined, the expression of Stra8 also began at P0.5 (Fig. 1A) . The expression profiles of Ngn3 and cKit showed a later onset of expression from P4.5 consistent with previous reports (Yoshida et al., 2004; Yoshida et al., 2006) .
Next, we validated the gene expression profiles with immunofluorescence or in situ hybridization focusing on the perinatal period from E17.5 to P1.5. We confirmed that spermatogonial genes were detected in a population of gonocytes at P0.5 and P1.5 (Fig. 1BIII, IV) . Interestingly, we noticed that some gonocytes had initiated the expression of these genes at E18.5, a day before birth (Fig. 1BII ). These nascent spermatogonia co-expressed GFRA1, RET and PLZF when they first emerged in E18.5 testes as revealed by double immuno-stainings ( Fig. 2A) . A subset of these nascent spermatogonia expressed Stra8 (Fig. 2A) . Therefore, the nascent spermatogonia constitute a mixture of undifferentiated spermatogonia and differentiating spermatogonia. The initiation of spermatogonial genes expression in gonocytes is asynchronous between the seminiferous cords (Fig. 1B) . To characterize the dynamics of this initiation, we quantified the proportion of PLZF-expressing gonocytes during the perinatal period. The quantification result showed that about 13% of gonocytes initiated PLZF expression at E18.5 and the number of nascent spermatogonia (i.e. PLZF + gonocytes) increased quickly postnatally (Fig. 2C) . These results indicate that nascent spermatogonia first emerge in the mouse testes a day prior to birth.
Relocated gonocytes are not necessarily nascent spermatogonia
The hallmarks of perinatal gonocytes are their relocation from the center to attach on the basal membrane of seminiferous cords and their reentry into the cell cycle (Nagano et al., 2000) . To know whether gonocyte relocation and reproliferation signify their transition into spermatogonia, we analyzed the relationship between these changes in cellular behaviors of the gonocytes and the expression of spermatogonial genes in the perinatal testes. We visualized gonocyte relocation by staining the basal membrane of seminiferous cords with anti-Laminin antibody and the cell membrane of gonocytes with anti-E-Cadherin antibody (Fig. 2B ). We considered a gonocyte relocated when its cell processes came in contact with the basal membrane. Consistent with previous report (Nagano et al., 2000), relocated gonocytes were observed in E18.5 testes and the number of relocated gonocytes increased after birth (Fig. 2B, D) . In the E18.5 testes, the majority of relocated gonocytes (69 ± 10%) did not express PLZF in contrast to expectation (Fig. 2BII, E) . The proportion of PLZF + relocated gonocytes increased after birth in which the majority of relocated gonocytes (71 ± 7%) expressed PLZF at P1.5 (Fig. 2C) . Interestingly, a small number of gonocytes (14.6 ± 0.5%) had relocated at E17.5, although the expression of spermatogonial genes had not started in the gonocytes (Fig. 2BI, D) . These results indicate that the expression of spermatogonial genes occurs independently of gonocyte relocation. Gonocytes were shown to reinitiate the cell cycle from P1.5 in C57BL/6J mice using BrdU incorporation assay (Nagano et al., 2000) . Consistently, we also observed mitotic germ cells in our P1.5 ICR mice ( Supplementary Fig. 1AIV, B) . Interestingly, we noticed that a small subset of P0.5 gonocytes (6 ± 4%) had reinitiated the cell cycle (Supplementary Fig. 1AIII, B) . This discrepancy could be due to the different mouse lines used. Next, we examined whether the mitotic germ cells express spermatogonial marker genes. We found that majority of mitotic germ cells (95 ± 4%) in P1.5 testes expressed PLZF protein (Supplementary Fig. 1C, D) . Taken together, these results show that nascent spermatogonia but not gonocytes reinitiated cell proliferation and that relocated gonocytes are not necessarily nascent spermatogonia. Goertz et al. (2011) showed that FOXO1 expression in P3 gonocytes begins to undergo cytoplasmic-to-nuclear translocation and proposed that this change in FOXO1 subcellular localization marks the transition of gonocytes to SSCs. Because we found that gonocytes initiate GST from E18.5, we were motivated to explore the subcellular localization of FOXO1 in our analysis of GST time course. Consistent with previous report (Goertz et al., 2011) , we also observed that majority of gonocytes exhibited FOXO1 cytoplasmic only (60 ± 11%) or both cytoplasmic and nuclear expression (40 ± 11%) in P0.5 testes (Fig. 3AIII, B) . Interestingly, we found that FOXO1 expression was mainly nuclear in pre-natal gonocytes (75 ± 5%) at E17.7 (Fig. 3AI, B) . Importantly, we noticed that FOXO1 underwent nuclear-to-cytoplasmic translocation in E18.5 gonocytes ( Fig. 3AII ). At E18.5, gonocytes with nuclear FOXO1 expression decreased to 10 ± 6%, correspondingly the gonocytes with cytoplasmic only (29 ± 5%) or both cytoplasmic and nuclear FOXO1 expression (61 ± 4%) increased (Fig. 3B) .
FOXO1 nuclear-to-cytoplasmic translocation signifies GST
The coincidental timing of FOXO1 nuclear-to-cytoplasmic translocation and the initiation of GST in E18.5 gonocytes led us to speculate that these two events are correlated. To test this speculation, we examined the expression of FOXO1 and GFRA1 in the perinatal testes (Fig. 3C ). We found that FOXO1 nuclear-to-cytoplasmic translocation is correlated with the expression of GFRA1 (Fig. 3CII-IV) . Quantification of FOXO1 subcellular localization and GFRA1 expression in E18.5 gonocytes revealed that majority of gonocytes with cytoplasmic FOXO1 expression (80 ± 2%) expressed GFRA1 (Fig. 3D ). Taken together, we identified FOXO1 nuclear-to-cytoplasmic translocation as a novel signature of GST.
GST requires FGF signaling
Having characterized GST, we next investigated how this process is regulated in the mouse testes. We utilized in vitro culture of E17.5 testicular explants (a day prior to GST initiation) with signaling inhibitors for 3 days to identify a novel signaling pathway that regulates GST (Fig. 4A) . We focused on BMP (Bone Morphogenetic Protein), FGF (Fibroblast Growth Factor) and TGFβ/Activin/Nodal signalings because these signaling pathways were previously shown to regulate germ cell fates at earlier developmental stages. BMP signaling is required for the specification of PGCs (Lawson et al., 1999; Ying et al., 2000) while FGF and Nodal signalings regulate gonadal sex determination (Colvin et al., 2001; Wu et al., 2013) .
We first examined changes in spermatogonial genes expression after culture with qRT-PCR. The expression of Ddx4 (also known as mouse Vasa homolog, Mvh), an ATP-dependent RNA helicase which expression begins in the gonocytes ( Fig. 1 ) and is maintained until the post-meiotic stage (i.e. spermatids/primary oocytes) (Fujiwara et al., 1994) , increased in testicular explants cultured with signaling inhibitors (Fig. 4B ). This is likely due to secondary effects of inhibitors changing the germ/soma ratio. Nevertheless, we opted to normalize germ cellspecific genes with Ddx4 (instead of a house keeping gene, Gapdh) to better reflect expression changes in the germ cells. In the presence of BMP receptors (ALK2/3) inhibitor (LDN193189, BMPi), the expression of spermatogonial genes was not affected except Stra8 (Fig. 4B ). Whereas testicular explants treated with TGFβ/Activin/Nodal signaling inhibitor (SB431542, Nodali) significantly decreased the expression of Gfra1, Nanos2 and Stra8, but not those of Ret and Plzf (Fig. 4B ). Among the three signaling inhibitors examined, we found that FGF receptor inhibitor (SU5402, FGFRi) treatment significantly suppressed the expression of all spermatogonial genes (Fig. 4B ). We confirmed that GFRA1 protein expression was suppressed in FGFRi-treated explants (Fig. 4FI ). In addition, among the more recently described markers of SSCs (Sun et al., 2015; Aloisio et al., 2014; Zhang et al., 2008) , we found that the expression of Id4 and Pax7 but not Bmi1 was significantly decreased in FGFRitreated explants ( Supplementary Fig. 2A ). These results indicate that FGF signaling is required for GST.
Therefore, we next focused on FGFRi treatment and analyzed its effects on GST progression. In the FGFRi-treated explants, gonocyte relocation was not significantly changed (although we could see a decreasing trend) (Fig. 4CI, D) . On the other hand, gonocyte reproliferation was significantly suppressed with FGFRi treatment (Fig. 4CII, E) . This is consistent with our observation that nascent spermatogonia but not gonocytes resumed the cell cycles ( Supplementary Fig. 1C, D) . Furthermore, we found that FOXO1 nuclear-to-cytoplasmic translocation was disturbed (Fig. 4FII) . Quantification of FOXO1 subcellular localization revealed a significant reduction in gonocytes with cytoplasmic FOXO1 expression and a corresponding increase in gonocytes retaining nuclear FOXO1 expression (Fig. 4G ). Taken together, these results demonstrate that FGF signaling is required for GST:FGFRi treatment suppressed spermatogonial genes expression, gonocyte reproliferation and FOXO1 nuclear-to-cytoplasmic translocation.
FGFRi suppresses MEK/ERK and PI3K/Akt pathways in gonocytes, and PI3Ki partially recapitulates FGFRi's phenotypes
To understand how FGF signaling regulates GST, we looked for its downstream signaling cascades which include Jak/Stat (Janus kinase/ signal transducer & activator of transcription), PLCγ (Phosphoinositide phospholipase C), MEK/ERK and PI3K/Akt (Lanner and Rossant, 2010) . In particular the MEK/ERK and PI3K/Akt pathways were previously shown to be required for GSC propagation in vitro (Lee et al., 2007; Hasegawa et al., 2013) . We used phosphorylated ERK (pERK, active form of ERK) as an indicator of MEK/ERK pathway activation. Since we could not optimize pAkt immuno-staining in our specimens (data not shown), we made use of phosphorylated S6 (pS6, active form of S6, a downstream target of mTOR (mammalian target of rapamycin) pathway) as an alternative readout of PI3K/Akt pathway activation. This is because the PI3K/Akt and mTOR pathways are intricately interconnected (Bhaskar and Hay, 2007) . We found that the activation of MEK/ERK and PI3K/Akt pathways began in E18.5 gonocytes which coincided with the timing of GST ( Supplementary Fig. 3A, B) .
Therefore, we focused on the MEK/ERK and PI3K/Akt pathways in subsequent experiments. We paid our attentions to the effects on the gonocytes in this report, although both the testicular somatic cells and germ cells were exposed to the inhibitor in our culture system. We found that FGFRi treatment suppressed both the expressions of pERK and pS6 in the gonocytes (Fig. 5A) . These results show that both the MEK/ERK and PI3K/Akt pathways were inhibited in the gonocytes upon FGFRi treatment. To validate the role of the MEK/ERK and PI3K/ Akt pathways during GST, we inhibited the pathways in testicular explants with inhibitors (Fig. 5B) . Since simultaneous addition of MEK inhibitor (PD0325901, MEKi) and PI3K inhibitor (LY294002, PI3Ki) to culture resulted in severe developmental perturbation of testicular explants (data not shown), we analyzed the effects of individual inhibitors. As expected, pERK but not pS6 expression was inhibited in gonocytes of MEKi-treated explants ( Supplementary Fig. 4AI, II) . Similarly, pS6 expression was inhibited in gonocytes in the presence of PI3Ki (Supplementary Fig. 4AII ). Unexpectedly, PI3Ki treatment also decreased pERK expression in the gonocytes (Supplementary Fig. 4AI ).
Gene expression analysis revealed that MEKi suppressed the expression of spermatogonial genes except Nanos2 and Stra8 (Fig. 5C) . The expression of Stra8 was highly elevated while Nanos2 expression was not significantly changed in contrary to FGFRi treatment (Fig. 5C ). We found that GFRA1 protein expression was decreased in gonocytes after MEKi treatment (Fig. 5DI) , indicating that GST was repressed. Alternatively, this may suggest that nascent spermatogonia were formed but precociously differentiated. Indeed, the expression of Sohlh1 and Sohlh2, two other germ cell-specific genes essential for spermatogonial differentiation (Suzuki et al., 2012) increased in MEKi-treated explants (Fig. 5C) . Furthermore, the expression of Sycp3 a meiotic marker (di Carlo et al., 2000) also increased after MEKi treatment (Fig. 5C ). On the other hand, gonocyte relocation was reduced in MEKi-treated explants ( Supplementary Fig. 4BI, C) . We noticed that MEKi treatment resulted in partial degeneration of the basal membrane which was not observed in FGFRi-treated explants ( Supplementary Fig. 4BI , open arrowheads). Whereas, gonocytes in MEKi-treated explants reentered the cell cycle as the control ( Supplementary Fig. 4BII, D) .
In contrast to MEKi, PI3Ki treatment partially perturbed GST. The expression of spermatogonial genes was suppressed except Ret and Nanos2 (Fig. 5C ). Ret expression was increased and Nanos2 expression was unchanged (Fig. 5C ). The expression of GFRA1 protein was inhibited in gonocytes after PI3Ki treatment (Fig. 5DI) . In addition, the expression of differentiating spermatogonial markers Stra8, Sohlh2 and cKit was suppressed (Fig. 5C ). Similar to FGFRi treatment, gonocyte relocation proceeded but gonocyte reproliferation was inhibited in PI3Ki-treated explants ( Supplementary Fig. 4BII, D) . Furthermore, PI3Ki treatment repressed FOXO1 nuclear-to-cytoplasmic translocation in the gonocytes where gonocytes with cytoplasmic FOXO1 expression were significantly decreased while those with nuclear FOXO1 expression increased (Fig. 5DII, E) . This is consistent with previous observation that Pdk1 (3-phosphoinositide-dependent protein kinase 1) knockout significantly decreased the proportion of spermatogonia with cytoplasmic FOXO1 expression in P3 and P14 mutant testes as a result of Akt hypoactivation (Goertz et al., 2011) . On the contrary, gonocytes with cytoplasmic FOXO1 expression significantly increased in MEKi-treated explants (Fig. 5DII, E) . Taken together, these results show that PI3Ki but not MEKi partially recapitulated FGFRi's inhibition of GST in cultured explants.
RA signaling acts downstream of FGF signaling but is dispensable for GST
Because the FGF/PI3K/Akt signaling axis inhibited spermatogonial differentiation in gonocytes and RA signaling is known to regulate spermatogonial differentiation, we next examined the relationship between FGF and RA signalings. We speculate that FGFRi treatment suppresses RA signaling in the testicular explants. FGFRi could suppress RA signaling through the inhibition of RA synthesis, promotion of RA degradation or suppression of RAR receptors expression. To evaluate these possibilities, we examined the expression of selected genes involved in each processes by qRT-PCR ( Supplementary Fig. 2B ). Most of these genes were expressed in the somatic cells of the testis (i.e. Sertoli cells, Leydig cells and peritubular myoid cells) except Rarγ which is expressed in spermatogonia (Vernet et al., 2006b) . Among the three genes that encode enzymes for the conversion of retinal to RA, we found that the expression of Aldh1a2 and Aldh1a3 was decreased except Aldh1a1 in FGFRi-treated explants ( Supplementary Fig. 2B ). In addition, the expression of RA receptors (Rarα, Rxrβ & Rarγ) was decreased after FGFRi treatment (Supplementary Fig. 2B ). Furthermore, the expression of RA catabolic genes (Cyp26a1, Cyp26b1 & Cyp26c1) was also decreased in FGFRi-treated explants ( Supplementary Fig. 2B ). These results indicate that FGFRi treatment may suppress spermatogonial differentiation via the inhibition of expression of most RA components in cultured explants.
To validate the FGF/RA signaling axis more directly, we manipulated RA signaling in testicular explants with inhibitors (Fig. 6A) . We inhibited RA signaling by RA receptor antagonist (AGN193109, RARi) or elevated RA signaling by inhibiting the degradation of RA using Cytochrome P450 inhibitor (Ketoconazole, CYPi). We confirmed that RARi treatment significantly decreased the expression of Stra8 in the cultured explants (Fig. 6B) . However, the expression of other spermatogonial genes was not significantly changed in RARi-treated explants (Fig. 6B,  DI) . This indicates that GST was unperturbed in gonocytes after RARi treatment. Indeed, both gonocyte relocation and reproliferation were not inhibited in the RARi-treated explants ( Supplementary Fig. 5A-C) . Similarly, RARi treatment did not suppress pERK and pS6 expression in gonocytes (Fig. 6C) . Furthermore, FOXO1 nuclear-to-cytoplasmic translocation normally occurred in gonocytes after RARi treatment (Fig. 6DII, E) .
In CYPi-treated explants, RA signaling was elevated as evidenced by a significant increase in Stra8 expression (Fig. 6B) . This indicates that spermatogonial differentiation was promoted in the nascent spermatogonia. Correspondingly, the expression of Nanos2 and Plzf was significantly decreased by CYPi treatment in cultured explants (Fig. 6B) . However, the expression of Gfra1 and Ret was not significantly reduced in CYPi-treated explants (Fig. 6B) . We confirmed that gonocytes initiated GFRA1 protein expression after CYPi treatment (Fig. 6DI) . As expected, gonocyte relocation was not perturbed by CYPi treatment (Supplementary Fig. 5AI, B) . However, gonocyte reproliferation was increased in CYPi-treated explants ( Supplementary Fig. 5AII, C) . On the other hand, CYPi treatment did not affect the expression of pERK and pS6 in gonocytes (Fig. 6C) . In addition, FOXO1 nuclear-to-cytoplasmic translocation proceeded in gonocytes treated with CYPi (Fig. 6DII, E) . Taken together, these results indicate that RA signaling functions downstream of FGF signaling but the role of RA signaling is limited to the regulation of spermatogonial differentiation.
GDNF signaling functions downstream of FGF signaling and Gfra1KO partially perturbs GST
Since GDNF signaling is strongly affected in FGFi-treated testes due to the repression of both Gfra1 and Ret expression, we expect that FGF signaling may work via GDNF signaling. Thus, we next analyzed Gfra1-null (Gfra1KO) testes. Again we employed in vitro organ culture because Gfra1-null mice die within 24 h after birth (Cacalano et al., 1998; Enomoto et al., 1998) (Fig. 7A) . We confirmed that germ cells expressed GFRA1 protein in the control but not in Gfra1KO explants (Fig. 7DI) . We found that pERK expression level was significantly reduced in Gfra1KO gonocytes (Fig. 7CI) . Nevertheless, we noticed that Gfra1KO gonocytes retained weak pERK expression (Fig. 7CI, open arrowheads) . This result shows that MEK/ERK pathway activation in gonocytes predominantly requires intact GDNF signaling but to a less extent its activation is also supplemented by other signaling(s) including FGF signaling.
In Gfra1KO explants, gonocyte relocation was not significantly inhibited ( Supplementary Fig. 6AI, B) . Gene expression analysis by qRT-PCR revealed that the expression of other spermatogonial genes (Ret, Nanos2, Plzf & Stra8) was not significantly changed in Gfra1KO explants (Fig. 7B ). This indicates that GST was not perturbed in Gfra1KO gonocytes. Indeed, FOXO1 nuclear-to-cytoplasmic translocation occurred in Gfra1KO gonocytes (Fig. 7DII, E) . Upon close examination, however we noticed a significant increase in gonocytes with both nuclear and cytoplasmic FOXO1 expression and a corresponding reduction in gonocytes with cytoplasmic FOXO1 expression in Gfra1KO explants (Fig. 7E ). This result shows that the clearance of nuclear FOXO1 expression requires intact GDNF signaling.
We further cultured Gfra1KO explants with RARi to achieve simultaneous inhibition of RA and GDNF signalings (Fig. 7A) , expecting that it may retard GST. However, RARi treatment did not significantly alter FOXO1 subcellular localization in gonocytes of Gfra1KO explants (Fig.  7DII, E) . Furthermore, we observed that pS6 expression (Fig. 7CII ) and gonocyte reproliferation ( Supplementary Fig. 6AII , C) were significantly repressed in Gfra1KO gonocytes with or without RARi treatment. We wonder whether gonocytes could not response to RA in the absence of GDNF signaling. Therefore, we cultured P0.5 Gfra1KO (and control) testicular explants with or without CYPi for 3 days (Supplementary Fig.  7A ). We found that Gfra1KO gonocytes (31 ± 3%) did resume the cell cycle, although it was significantly lower than the control (48 ± 1%) ( Supplementary Fig. 7B, C) . Moreover, CYPi significantly increased the proportion of mitotic germ cells in Gfra1KO explants (59 ± 3%) (Supplementary Fig. 7B, C) . Taken together, these results indicate that GDNF signaling functions downstream of FGF signaling for optimal activation of the MEK/ERK and PI3K/Akt pathways, clearance of nuclear FOXO1 expression and timely initiation of reproliferation in gonocytes during GST.
Discussion
In this study, we addressed when and how GST is initiated in the testes of ICR strain mice. We found that GST initiates in gonocytes as early as E18.5 and this initiation requires FGF signaling. Using a battery of organ culture experiments, we propose that FGF signaling acts upstream of GDNF and RA signalings to regulate GST in gonocytes (Fig. 8B) . In 2006, Naughton et al. (2006) transplanted whole testis of P0 Gdnf-, Gfra1-and Ret-null mutant mice and demonstrated that GNDF signaling positively regulates nascent SSC proliferation and maintains them in an undifferentiated state. On the other hand, studies using in vitro culture of purified P2 germ cells with RA or subcutaneous injection of RA into P2 mice demonstrated that RA signaling stimulates the differentiation of nascent spermatogonia (Zhou et al., 2008a; Snyder et al., 2010 ). Here we showed that pharmacological inhibition of FGF signaling in perinatal testicular explants suppressed the downstream effects of both GDNF and RA signalings, namely gonocyte reproliferation, undifferentiated spermatogonial markers expression and spermatogonial differentiation.
We identified FOXO1 nuclear-to-cytoplasmic translocation as a novel feature that signifies GST initiation in gonocytes (Fig. 8A) . It is of interest to note that this translocation is transient because FOXO1 expression gradually becomes restricted to the nuclei of future SSCs beginning from P3 (Goertz et al., 2011) . The serine/threonine-specific protein kinases including ERK and Akt were previously shown to phosphorylate FOXOs and promote their cytoplasmic localization (Brunet et al., 1999; Asada et al., 2007) . The initiation of spermatogonia marker genes expression and the activation of the MEK/ERK and PI3K/Akt pathways in E18.5 gonocytes correlate well with FOXO1 nuclear-to-cytoplasmic in these transiting cells. We showed that FOXO1 nuclear-to-cytoplasmic translocation in gonocytes requires FGF signaling. The inhibition of FGF signaling by FGFRi suppressed both the MEK/ERK and PI3K/Akt pathways in gonocytes. Furthermore, the inhibition of the PI3K/Akt pathway by PI3Ki (which also indirectly suppressed the MEK/ERK pathway) suppressed FOXO1 nuclear-to-cytoplasmic translocation in gonocytes.
It has long been proposed that the gonocytes give rise to both the undifferentiated spermatogonia and differentiating spermatogonia during GST (de Rooij, 1998; Yoshida et al., 2006) . In agreement with this proposal, we showed that nascent spermatogonia constitute a mixture of undifferentiated spermatogonia and differentiating spermatogonia. However a definitive evidence showing the cell fates of nascent spermatogonia is lacking, in particular whether these cells contain SSCs. We believe that germ-cell transplantation assays (Brinster and Zimmermann, 1994) are needed in future to clarify the cell fates of nascent spermatogonia.
The hallmarks of perinatal gonocytes are their relocation from the center to the periphery of seminiferous cords and their reentry into of cell cycle (Nagano et al., 2000) . However, we did not find correlation between gonocyte relocation and GST entry in gonocytes. This indicates that gonocyte relocation is regulated by independent mechanism(s). Indeed, the platelet-derived growth factor (PDGF) signaling was previously implicated in the regulation of gonocyte relocation and reproliferation (Basciani et al., 2008) . Basciani et al. (2008) showed that gonocytes express PDGF receptor and found that the gonocyte relocation and reproliferation were decreased after 5 consecutive days of imatinib (an inhibitor of PDGF receptor) administration to newborn male mice. Nevertheless, some gonocytes did relocated to the basal membrane and spermatogenesis was fully recovered in older animals (Basciani et al., 2008) . Recently, a transcription factor RHOX10 (X-linked reproductive homeobox gene 10) was shown to be cell-autonomously required in gonocytes for their relocation (Song et al., 2016) . In Rhox10 mutants, genes that encode proteins involving in cell migration were downregulated in gonocytes and SSC establishment was defective (Song et al., 2016) . Therefore, both the extrinsic and intrinsic mechanisms regulate gonocyte relocation in the mouse testes. Fig. 8 . Graphic summary of this study. (A) Characterization of GST in the murine testes. GST is initiated in the gonocytes as early as E18.5. During GST, gonocytes initiate the expression of spermatogonial marker genes while FOXO1 expression in the gonocytes undergoes nuclear-to-cytoplasmic translocation. Therefore, nascent spermatogonia can be distinguished from the gonocytes by the expression of spermatogonial marker genes including GFRA1 and cytoplasmic FOXO1 expression. (B) Regulation of GST in the murine testes. FGF signaling sits atop a signaling hierarchy which includes GDNF and RA signalings. The downstream activation of both the MEK/ERK and PI3K/Akt pathways is necessary for FOXO1 nuclear-to-cytoplasmic translocation in the gonocytes. In addition, the MEK/ERK pathway maintains nascent spermatogonia in an undifferentiated state whereas the PI3K/Akt pathway promotes proliferation and differentiation in nascent spermatogonia.
Our analyses using in vitro culture of perinatal testicular explants demonstrated a crucial requirement of FGF signaling in regulating GST. In mouse, there are four FGF receptors -FGFR1, FGFR2, FGFR3 and FGFR4. In the rat fetal testes, FGFR1 protein was detected in Leydig cells, the surrounding mesenchyme, Sertoli cells and gonocytes; whereas FGFR3 proteins was detected only in gonocytes (Cancilla and Risbridger, 1998) . We confirmed that all FGF receptors were expressed in the perinatal testes, in which Fgfr1 showed highest expression level by qRT-PCR (data not shown). All cell types in the perinatal testes expressed Fgfr1 but the Sertoli cells, with higher expression levels detected in the interstitial cells and peritubular myoid cells by in situ hybridization (data not shown). However, a recent report by Li et al. (2014) showed that the deletion of either Fgfr1 or Fgfr2 in the germline did not affect spermatogenesis. We also confirmed their observation by conditional ablation of Fgfr1 in the germline using Nanos3
Cre (data not shown). This is likely due to the redundancy of FGF receptors. In addition, Fgfr3 and Fgfr4 knockout mice were shown to be fertile (Colvin et al., 1996; Weinstein et al., 1998) indicating that they are not essential for germ cell development. Future investigation using double conditional ablation of Fgfr1 and Fgfr2 would be useful to address the function of FGF signaling in the gonocytes during GST. Our present study did not distinguish whether FGF signaling acted directly on the perinatal gonocytes or indirectly on the testicular somatic cells (or a combination of both). Furthermore, it remains unknown which FGF ligands mediate FGF signaling in the perinatal testes. FGF1-5 and FGF8 were expressed in the fetal rat testes at E19.5 stage (Cancilla et al., 2000) . In the mouse, FGF2 was shown to positively regulate proliferation of cultured germline stem cells (Ishii et al., 2012) . Interestingly, FGF2 treatment increased pseudopodia formation of mouse PGCs and enhanced their migration in cultured embryo slices (Takeuchi et al., 2005) . Therefore, the expression and function of FGF2 and other FGFs in the perinatal testes warrant further investigations. On the other hand, it is unknown whether gonocytes intrinsically determine their timing of GST entry independent or in addition to the external signals. We believe that elucidating both the extrinsic and intrinsic regulations of GST is essential to uncover the mechanism of cell-fate decision making in perinatal gonocytes which is pertinent to male fertility.
Materials and methods
Animals
All mice were maintained in accordance with National Institute of Genetics (NIG) guidelines, and all experimental procedures carried out were approved by the Committee for Animal Care and Use in NIG. Animals were staged by designating the day on which a copulatory plug was detected as E0.5 and the day of birth as P0.5. Animals used in this study were in ICR background (CLEA Japan). The Gfra1 Δ mouse line was previously described in (Uesaka et al., 2007) . Gfra1 Δ/+ mice were crossed to obtain Gfra1 Δ/Δ (Gfra1KO) fetuses. For gene expression profiling, three animals (littermates) (n = 3) were sampled from each indicated development stages. All organ culture experiments were also performed with three biological replicates in both the control and experimental groups.
Organ culture
E17.5 or P0.5 testes were dissected in ice-cold PBS to remove tunica albuginea and cut into quarters. These testicular explants were cultured for three days following previously reported method (Hiramatsu et al., 2010) . Briefly, the explants were placed on 5 μm polycarbonate membrane filter (Millipore) floating on 10% horse serum/DMEM (containing 100 units per mL of penicillin and streptomycin) in 24-well tissue culture plates at 37°C, 5% CO 2 for 72 h. Signaling inhibitors used were ALK2,3,6 inhibitor (BMP signaling) -1 μM LDN193189 (Stemgent), FGF receptor inhibitor -40 μM SU5402 (Calbiochem), TGFβ receptor inhibitor (Nodal signaling) -40 μM SB431542 (Sigma-Aldrich), MEK inhibitor -20 μM PD0325901 (Wako), PI3K inhibitor -30 μM LY294002 (Wako), RA receptor antagonist -5 μM AGN193109 (Toronto Research Chemicals) and cytochrome P450 inhibitor -10 μM Ketoconazole (Wako). Inhibitors were dissolved in dimethyl sulfoxide (Sigma-Aldrich) and control explants were treated with equal volume of the solvent.
Quantitative reverse transcription polymerase chain reaction (qRT-PCR)
For gene expression profiling of spermatogonial genes, whole testes from E13.5 to P5.5 wildtype mice were collected. For organ culture experiments, testicular explants were harvested. Total RNAs were isolated from the specimens with RNeasy Mini Kit (Qiagen) and followed by cDNA synthesis using oligo(dT) primer and SuperScript III (Invitrogen) according to manufacturer's instructions. Real-time quantitative reverse transcription-PCR (qRT-PCR) was performed with technical duplicates using KAPA SYBR Fast qPCR kit (KAPA Biosystems) and Thermal Cycler Dice (Takara). Germ cell-specific genes were normalized with Ddx4 (also known as mouse Vasa homolog Mvh). Non-germ cell-specific genes were normalized with a housekeeping gene Gapdh (glyceraldehyde-3-phosphate dehydrogenase). Primer sequences are listed in Supplementary Table 1 .
Immunofluorescence & in situ hybridization
Whole testes or testicular explants (for culture experiments) were fixed in 4% paraformaldehyde (Nakalai)/PBS at 4°C overnight. Then the specimens were equilibrated in sterile 30% sucrose/PBS, embedded in 22-oxacalcitriol (OCT) compound (Sakura Finetek) and sectioned to 6 μm thickness. For immunofluorescent staining, sections were pretreated with Antigen Unmasking Solution (Vector Laboratories) or Target Retrieval Solution (Dako) at 105°C for 5 min. This was followed by blocking with 3% skimmed milk/PBST (0.1% Tween 20/PBS) for 1 h at room temperature and incubated with primary antibodies in Can Get Signal A buffer (TOYOBO) at 4°C overnight. The antibodies used and their dilutions were goat anti-GFRA1 (1:500, Neuromics), goat anti-RET (1:500, Neuromics), rabbit anti-PLZF (1:500, Santa Cruz Biotechnology), rabbit anti-phosphorylated Histone 3 (1:500, Cell Signaling Technology), mouse anti-phosphorylated Histone 3 (1:20, gift from Hiroshi Kimura (Hayashi-Takanaka et al., 2009)), rabbit anti-phosphorylated ERK1/2 (1:500, Cell Signaling Technology), rabbit anti-phosphorylated S6 (1:500, Cell Signaling Technology), rabbit anti-FOXO1 (1:100, Cell Signaling Technology), goat anti-E-Cadherin (1:1000, R&D Systems), rabbit anti-Laminin (1:1000, Sigma-Aldrich), rat anti-Laminin (1:100, MP Biomedicals), rabbit anti-MVH (1:500, Abcam) and rat anti-TRA98 (1:500, gift from Yoshitake Nishimune). After rinsing, the sections were incubated with appropriate secondary antibody conjugated with Alexa488 or Alexa594 or Alexa647 (1:500, Life Technologies) or CY5 (1:500, Rockland Immunochemicals) in PBST at 4°C overnight.
Stra8 and Ret expressions (in Figs. 1B, 2A) were detected by in situ hybridization. Templates were cDNA cloned in pBluescript II SK vectors: Stra8 cDNA vector (a gift from Atsushi Suzuki) and Ret cDNA vector (a gift from Kazuteru Hasegawa). Antisense RNA probes were synthesized using DIG RNA labeling kit (Roche Diagnostics). In situ hybridization was performed as previously described (Hasegawa et al., 2013) . Hybridized probes were detected by horseradish peroxidase (HRP)-conjugated anti-DIG antibody (1:200, Roche Diagnostics). The signals were detected using Tyramide Signal Amplification (TSA) system (Perkin Elmer) according to manufacturer's instructions. Nuclear counterstain was performed with 4′,6′-diamidino-2-phenylindole (DAPI, 100 ng/mL) (Sigma-Aldrich). Images were taken using a fluorescent microscope (Olympus BX61) or confocal microscope (Olympus FV1200) and processed with Adobe Photoshop.
Quantification of germ cells
Quantitative analyses of gonocyte relocation, gonocyte reproliferation and FOXO1 subcellular localization were expressed in the percentage of total germ cells evaluated. In all quantification, three biological replicates (n = 3) from the control and experimental groups were evaluated. Within the group, two to four testicular cross sections (that are at least 10 sections or 60 μm apart) from each animal were examined. A composite of around 1000 germ cells were counted in each group. The mean value and standard deviation were derived with data from the three biological replicates. In all graphs, the mean values were plotted with the standard deviation.
Statistics
Statistical analyses were performed using Student's t-test and statistical significance was defined as p b 0.05.
